Protocol Ledger

NCT03295981 · Phase III · RECRUITING

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Interventional Phase III clinical trial protocol NCT03295981 sponsored by St. Louis University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-05-03 Enrollment: 120 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03295981
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)120 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03295981
Protocol FieldVerified Registry Value
NCT IdentifierNCT03295981
Consolidated Lead SponsorSt. Louis University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment120 participants (ESTIMATED)
Registered Start Date2018-05-03
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI